CHM chimeric therapeutics limited

Ann: AML patient achieves Complete Response in CHM CORE-NK trial, page-65

  1. 5,509 Posts.
    lightbulb Created with Sketch. 758
    Paradigm (PAR) have had remarkable results and are awaiting the go ahead to start ph3 trials. Until a couple of days ago they had a mc of mid $70m. They too have an egotistical leader that has destroyed the company and are now looking for money for ph3. Given the destruction of the sp due to his lack of leadership and selfishness of rewarding himself with options, they are in no position to be dictating terms with any sort of partnership or deal. The point is, the science is far from everything. Without a board that can be trusted, the science means nothing.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.